IGC Pharma (IGC) Capital Expenditures (2010 - 2025)
IGC Pharma (IGC) posted quarterly Capital Expenditures of $29000.0 for Q3 2025, little changed year-over-year from $29000.0 in Q3 2024, and up 262.5% quarter-over-quarter from $8000.0 in Q2 2025.
IGC Pharma (IGC) Capital Expenditures (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Capital Expenditures for 16 consecutive years, with $29000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Capital Expenditures changed 0.0% year-over-year to $29000.0; the TTM figure through Sep 2025 stood at $82000.0 (down 45.33% YoY), while the FY2026 annual figure was $1000.0, down 99.11% from the prior year.
- Capital Expenditures grew to $29000.0 in Q3 2025 per IGC's latest filing, from $8000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.5 million in Q1 2021 and bottomed at -$404000.0 in Q3 2022.
- Historically, Capital Expenditures has averaged $121210.5 across 5 years, with a median of $29000.0 in 2024.
- On a YoY basis, Capital Expenditures climbed as much as 2178.57% in 2022 and fell as far as 469.01% in 2022.
- IGC Pharma's Capital Expenditures stood at -$28000.0 in 2021, then surged by 2178.57% to $582000.0 in 2022, then slumped by 88.32% to $68000.0 in 2023, then slumped by 60.29% to $27000.0 in 2024, then rose by 7.41% to $29000.0 in 2025.
- Business Quant data shows IGC's Capital Expenditures at $29000.0 in Q3 2025, $8000.0 in Q2 2025, and $18000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Sep 30, 2023 | 35,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |